Tianjin Binhai hopes for biopharm industry development, commits RMB 10billion, GBI

Release Date: 2009-07-31

Tianjin Binhai New Area, a science and technology park, plans to invest RMB 10 billion over the next five years to promote biopharmaceutical industry development, Xinhuanet.com reported July 29. RMB 5 billion of the investment will go into the Biopharmaceutical Industry Development Fund to support industry-related companies.


Currently, there are over 100 biopharmaceutical companies in the Tianjin Binhai New Area.
Type: NORMAL
Company: GBI
Country: 中国
Url: http://www.gbipharma.com/cpbheadline.asp?newsid=2010378
 
This website requires Flash Player 9 or later. If you can not view this site you probably need to update your system with this plug-in for your browser.